New study alerts to the risk of poor quality medicines used to prevent and treat cardiovascular disease

The recently published ‘The quality of medical products for cardiovascular diseases: a gap in global cardiac care’ paper, shows that one fifth of medicines reported as sampled in the literature were substandard or falsified. The research was carried out by experts from the MORU Tropical Health Network together with IDDO scientists. Given the Read more…

U.S. Pharmacopeia’s new resources to fight substandard and falsified COVID-19 vaccines

Fight the Fakes’ member U.S. Pharmacopeia (USP) has recently launched a number of valuable materials to help identify substandard and falsified COVID-19 vaccines, which are free to the public. Substandard and falsified vaccines erode the public’s trust in vaccines and hinder our ability to control the COVID-19 pandemic. To help Read more…

ICMRA – Common technical denominators for traceability systems for medicines to allow for interoperability

The International Coalition of Medicines Regulatory Authorities (ICMRA) has development of a policy paper on national traceability systems for medical products with a strong focus on interoperability. Interoperability is key in the fight against fake medicines as it enables common technical denominators that facilitate the exchange and use the information on medicines Read more…

UPDATE: IDDO’s Medical Product Quality Reports on Covid-19 Supplies and Vaccines

In face of the current Covid-19 pandemic, the Infectious Diseases Data Observatory (IDDO) has been developing several Medical Product Quality Reports about substandard and falsified (SF) COVID-19 medical products and COVID-19 vaccines, which include data from scientific literature, public alerts and warnings, and lay press from across the world.  These monthly Read more…

Combatting Substandard and Falsified medicines during COVID-19 pandemic

Fight The Fakes Alliances’ member U.S. Pharmacopeia (USP) recently hosted an online workshop on ‘Combatting Substandard and Falsified medicines during COVID-19 pandemic’. In this workshop, composed of 6 sessions, USP experts and other relevant actors gave an overview of the work they carried out to detect substandard and falsified medicines during current Read more…